Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. [electronic resource]
Producer: 19990419Description: 1286-93 p. digitalISSN:- 0735-1097
- Adult
- Aspirin -- administration & dosage
- Biomarkers -- blood
- Cholesterol -- blood
- Drug Synergism
- Drug Therapy, Combination
- Fibrinopeptide A -- drug effects
- Follow-Up Studies
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Hypercholesterolemia -- blood
- Male
- Middle Aged
- Peptide Fragments -- drug effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Prognosis
- Prothrombin -- drug effects
- Safety
- Simvastatin -- administration & dosage
- Thrombin -- antagonists & inhibitors
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.